Literature DB >> 23373889

Primary localized cutaneous nodular amyloidosis successfully treated with cyclophosphamide.

Philip L Tong1, William A Walker, Ross J Glancy, Julian P Cooney, Kurt Gebauer.   

Abstract

Primary localized cutaneous nodular amyloidosis (PLCNA) is a rare subtype of localized cutaneous amyloidosis and can be associated with various connective tissue disorders. It can be difficult to treat and past therapies include surgical excision, dermabrasion, electrodessication and curettage, cryotherapy and laser therapy. We present a case of a middle-aged woman with PLCNA associated with CREST (calcinosis, Raynaud phenomenon, oesophageal motility disorders, sclerodactyly and telangiectasia) syndrome and Sjögren's syndrome responding to cyclophosphamide with no new amyloid deposits and resolution of skin ulceration after many years of resistance to drug therapy. It is important to monitor these patients for progression into systemic amyloidosis.
© 2011 The Authors. Australasian Journal of Dermatology © 2011 The Australasian College of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 23373889     DOI: 10.1111/j.1440-0960.2011.00770.x

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN: 0004-8380            Impact factor:   2.875


  3 in total

1.  Primary Localized Cutaneous Nodular Amyloidosis and Limited Cutaneous Systemic Sclerosis: Additional Cases with Dermatoscopic and Histopathological Correlation of Amyloid Deposition.

Authors:  Laura Atzori; Caterina Ferreli; Caterina Matucci-Cerinic; Luca Pilloni; Franco Rongioletti
Journal:  Dermatopathology (Basel)       Date:  2021-07-02

2.  First Case of Nodular Localized Primary Cutaneous Amyloidosis Treated With Bortezomib and Dexamethasone.

Authors:  Noman Ahmed Jang Khan; Emma Nellhaus; Doreen Griswold; Muhammad Omer Jamil
Journal:  J Investig Med High Impact Case Rep       Date:  2021 Jan-Dec

3.  Nodular cutaneous amyloidosis effectively treated with intralesional methotrexate.

Authors:  James Raymond; James Choi
Journal:  JAAD Case Rep       Date:  2016-09-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.